AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> MutationsKatharine Yen, Shinsan M. Su, Erin Artin et al.|Cancer Discovery|2017Cited by 457
The RhoGAP ARHGAP19 controls cytokinesis and chromosome segregation in T lymphocytesMuriel D. David, Jacques Bertoglio|Journal of Cell Science|2013Cited by 37